Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.
Poorva BindalMimi NajjarKelly KoehnAmandeep GodaraDouglas W SborovBrian McCluneKelley JullianCharlotte WagnerGhulam Rehman MohyuddinPublished in: Leukemia & lymphoma (2023)